Related Experiment Video
Updated: Jun 19, 2026
09:29
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Published on: October 29, 2015
30.2K
TRIMming down Flavivirus Infections
Marion Cannac1, Sébastien Nisole1
1Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, CNRS, 34090 Montpellier, France.
Viruses
|August 29, 2024
Summary
Flaviviruses, like dengue and Zika, are spreading globally. This review explores how tripartite motif (TRIM) proteins, part of the innate immune system, fight these viral infections.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Flaviviruses are a growing global health threat, transmitted by arthropods like mosquitoes and ticks.
- Mosquito-borne flaviviruses include dengue, Zika, and West Nile viruses, causing significant human disease.
- Tick-borne flaviviruses are also an emerging concern.
Purpose of the Study:
- To review the complex interactions between flaviviruses and tripartite motif (TRIM) proteins.
- To elucidate the roles of TRIM proteins in innate immunity against flaviviruses.
- To summarize viral strategies for evading or utilizing TRIM proteins.
Main Methods:
- Review of existing scientific literature on flavivirus-TRIM interactions.
- Analysis of direct and indirect antiviral mechanisms mediated by TRIM proteins.
- Examination of viral counter-strategies against TRIM proteins.
Main Results:
- Type I interferon-induced genes (ISGs) are crucial for innate antiviral defense.
- Certain TRIM proteins are identified as ISGs that inhibit flavivirus replication.
- TRIM proteins exhibit diverse functions, including direct viral inhibition and regulation of interferon response.
Conclusions:
- Flaviviruses interact with TRIM proteins through various direct and indirect mechanisms.
- Viruses have evolved strategies to counteract or exploit TRIM proteins for their replication.
- Understanding these interactions is key to developing new antiviral therapies.
Related Concept Videos
01:22Methods of reducing fever
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacological Methods of Reducing Fever:
01:18Yellow Fever
Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...